1 / 6

Chapter 5 Committee Writing Assignment

Chapter 5 Committee Writing Assignment. Four writing teams will start to draft their preliminary analysis of the PETMAN requirements that will be included in Chapter 5 of the report.

Download Presentation

Chapter 5 Committee Writing Assignment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 5 Committee Writing Assignment • Four writing teams will start to draft their preliminary analysis of the PETMAN requirements that will be included in Chapter 5 of the report. • Teams are indicated on each slide. Underlined names are the team leaders. Relevant requirement numbers are referenced. • Template to follow: For each topic on the subsequent slides (numbered 1-4): • Describe the requirements • Describe current technologies capabilities • Design challenges and how they may be addressed • Cost/Benefit Analysis & tradeoffs • Feasibility & Potential alternatives • Writing assignments are due from the team leaders by February 15.

  2. Mannequin Under-Ensemble Test Conditions (Darrell, Leo, Carlos, Paul, Lisa, Art, Zane) 3.2.5 • Human Physiological Simulation: Simulate Various Conditions of Temp, Perspiration, Respiration: 3.2.5, 3.3.4.1-3.3.4.3, 3.3.13 Leo • Sensor technologies (e.g. remote recording) • Sampling Rate and number of measurements (parameters) • Real-time data collection vs. closed-loop control of environmental conditions (Art) • IPE Penetration (Paul, Lisa, Zane, Art) 3.2.4, 3.3.5 Zane • Sensor Technologies • Sampling Rate • Real-time data collection (Art) SPEAKERS/Info. needed: Human heat generation (space suit community?), data from PD TESS, MIST protocol

  3. Control of PETMAN (Chris, Hadi, Dava, Art, Lisa, Sundaresan) • Freestanding or Supported (Chris, Hadi) 3.2.1 • Tethered or autonomous (Chris, Hadi) 3.2.1, 3.3.2 • Movement and Degrees of Freedom for Various Parts of the Body including Tracking (Chris, Hadi) 3.2.7, 3.2.8, 3.3.13 • Biomechanical Efficiency: Handling Typical Equipment (Rifle, etc.) (Chris, Dava) 3.2.2 (3.3.10.1 – 3.3.10.4), 3.2.8 • Ability to Don/Doff without Modification of PPE including attachments to Respirator, etc. e.g., M45 Mask, JSLIST Type Suits, Single and Two-piece Suits, Suit with Mask, Gloves, … (Lisa, Sundaresan) 3.2.2, 3.2.8 • Programmability (Chris, Art) 3.2.7 • Power: Source, Duration (Chris) 3.3.2 SPEAKERS/Info. needed: Battery technology, Sarcos & Berkeley (?) speakers (non-tethered technology), Robonaut (Ambrose)

  4. Material for PETMAN “Skin” (Sundaresan, Zane, Leo, Paul, Carlos) 3.2.3 • Properties 3.2.6 • Physiological Simulation • Create This Environment • Be Monitorable (3.3.13) • Withstand Traditional Agents 3.2.6 • Be Decontaminable (with cleaning agents--bleach and hydrogen peroxide) 3.3.11 • Doesn’t affect performance of or be affected by SERPACWA 3.2.2 • Interact with Clothing (ACU, BDU, Chem-Bio Suit) [Tactile Feel of Skin] 3.2.3 SPEAKERS/Info. needed: Sweating mannequin manufacturers

  5. Integration: How Feasible is an integrated system based on the State-of-the-art Technologies? Hadi, Sundaresan, Art, Darrell) • Robotics, Controls & Mechanisms (Hadi) • Materials (Sundaresan, Hadi) 3.3.12 • Tradeoffs, Risk Assessment, Cost-benefit SPEAKERS/Info. needed: Previous PETMAN bidders & their proposals

  6. PETMAN Drivers • Performance Testing • Man-in-Simulant Test (note: but PETMAN will eventually be tested with live agents in specified chamber being built at Dugway Proving Ground). • Failure Metrics: Time and Dosage • Operational Period (Chris) • Continuous/Discrete) • Tether or Not to Tether (Chris, Hadi) • Effect of chamber conditions on the system 3.2.6

More Related